Stuart Cobb - 18 Dec 2023 Form 3 Insider Report for Neurogene Inc. (NGNE)

Role
Chief Scientific Officer
Signature
/s/ Christine Mikail, as attorney-in-fact for Stuart Cobb
Issuer symbol
NGNE
Transactions as of
18 Dec 2023
Net transactions value
$0
Form type
3
Filing time
26 Dec 2023, 18:05:12 UTC
Next filing
14 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NGNE Stock Option (Right to Buy) 18 Dec 2023 Common Stock 22,680 $10.71 Direct F1
holding NGNE Stock Option (Right to Buy) 18 Dec 2023 Common Stock 15,352 $23.02 Direct F2
holding NGNE Stock Option (Right to Buy) 18 Dec 2023 Common Stock 22,680 $18.39 Direct F3
holding NGNE Stock Option (Right to Buy) 18 Dec 2023 Common Stock 13,514 $5.82 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase 22,680 shares of the Issuer's common stock. 25% of this option vested on October 7, 2021, with the remainder vesting in equal monthly installments through October 7, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
F2 This option represents a right to purchase 15,352 shares of the Issuer's common stock. 25% of this option vested on September 23, 2022, with the remainder vesting in equal monthly installments through September 23, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
F3 This option represents a right to purchase 22,680 shares of the Issuer's common stock. 25% of this option will vest on March 9, 2024, with the remainder vesting in equal monthly installments through March 9, 2027, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
F4 This option represents a right to purchase 13,514 shares of the Issuer's common stock and is fully vested.

Remarks:

Exhibit 24 - Power of Attorney